Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
SPONSORED CONTENTSupporting their skin – and your treatment planPrescription Diet Derm Complete is formulated to support the skin barrier against environmental irritants, year round. + Tell Me More